常见恶性肿瘤侧群细胞的研究进展

doi:10.3760/cma.j.issn.1673422X.2014.11.001

摘要/Abstract

摘要： 侧群细胞（SP）是指利用荧光染料Hoechst33342外排特性而筛选出来的细胞群体。SP具有肿瘤干细胞特性，在肿瘤的发生、发展中发挥极其重要的作用。目前国内外对于各类常见恶性肿瘤SP都进行了较为广泛的研究。对SP的研究可为肿瘤的诊断和治疗提供新的思路和方法。

关键词: 肿瘤, 肿瘤干细胞, 侧群细胞

Abstract: Side population cells (SPs) are selected by the efflux features of fluorescent dye Hoechst33342. SPs have the characteristics of cancer stem cells, and play an extremely important role in the occurrence and development of tumors. At present, the SPs in common types of malignant tumor have been studied extensively at home and abroad. The study of SPs may shed some light on the diagnosis and treatment of cancer.

Key words: Neoplasms, Neoplastic stem cells, Side population cells

朱超, 钱军. 常见恶性肿瘤侧群细胞的研究进展[J]. 国际肿瘤学杂志, 2014, 41(11): 801-804.

ZHU Chao, QIAN Jun. Side population cells of common tumor[J]. Journal of International Oncology, 2014, 41(11): 801-804.

参考文献

［1］ Xiang W, Shi JF, Li P, et al. Estimation of cancer cases and deaths attributable to infection in China［J］. Cancer Causes Control， 2011, 22(8):11531161. ［2］ Garvalov BK, Acker T. Cancer stem cells:a new framework for the design of tumor therapies ［J］. J Mol Med， 2011, 89(2):95107. ［3］ Valent P, Bonnet D, De Maria R, et al. Cancer stem cells definitions and terminology:the devil is in thedetails［J］. Cancer， 2012， 11(12):767775. ［4］ Shackleton M. Normal stem cells and cancer stem cells:similar and different［J］. Semin Cancer Biol， 2010, 20(2):8592. ［5］ Deonarain MP, Kousparou CA, Epenetos AA. Antibodies targeting cancer stem cells:a new paradigm in immunotherapy［J］.MAbs， 2009, 1(1):1225. ［6］ Hittelman WN, Liao Y, Wang L, et al. Are cancer stem cells radioresistant［J］. Future Oncol， 2010, 6(10):15631576. ［7］ Fong D, Yeh A, Naftalovich R, et al. Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line:towards targeting of cancer stem cells with phytochemicals［J］. Cancer Lett， 2010, 293(1):6572. ［8］ Lan L, Cui D, Nowka K, et al． Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes［J］. J Clin Endocrinol Metab， 2007, 92(9):36813688. ［9］ Todaro M, Iovino F, Eterno V, et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells［J］. Cancer Res， 2010, 70(21):88748885. ［10］ Mitsutake N, Iwao A, Nagai K, et al. Characterization of side population in thyroid cancer cell lines cancer stem like cells are enriched partly but not exclusively ［J］. Endocrinology， 2007, 148(4):17971803. ［11］张菀姣, 兰玲, 郑旭琴, 等. 甲状腺癌中类干细胞的侧群细胞的分离及鉴定［J］.南京医科大学学报， 2012, 32(5):585591. ［12］黄哲宙, 陈万青, 吴春晓, 等. 中国女性乳腺癌的发病和死亡现况——全国32个肿瘤登记点 2003—2007年资料分析报告［J］. 肿瘤， 2012, 23(6):435439. ［13］ Xu W, Lin H, Zhang Y, et al. Compound Kushen Injection suppresses human breast cancer stemlike cells by down regulating the canonical Wnt/catenin pathway［J］. J Exp Clin Cancer Res， 2011, 30:103. ［14］ Nakanishi T, Chumsri S, Khakpour N, et al. Side population cells in luminal type breast cancer have tumourinitiating cell properties,and are regulated by HER2 expression and signaling［J］. Br J Cancer， 2010, 102( 5):815826. ［15］杨晓宁, 周艳, 齐晓伟, 等. 成骨细胞诱导乳腺癌侧群细胞获得骨模拟特性的研究［J］. 第三军医大学学报， 2013, 35(11):11021106. ［16］孙欣, 樊翀, 胡丽娟, 等. Let7维持乳腺癌干细胞的特性及机制的研究［J］. 细胞与分子免疫学杂志， 2012, 28(8):789792. ［17］ Jemal A, Bray F, Center MM, et al. Global cancer statistics［J］. CA Cancer J Clin， 2011, 61(2):6990. ［18］ Li H, Gao Q, Guo L, et al. The PTEN/PI3K/Akt pathway regulates stemlike cells in primary esophageal carcinoma cells［J］. Cancer Biol Ther， 2011, 11(11)：950958. ［19］ Yu X, Jiang X, Li H, et al. miR203 Inhibits the proliferation and selfrenewal of esophageal cancer stemlike cells by suppressing stem renewal factor Bmi1［J］. Stem Cells Dev， 2014, 23(6):576585. ［20］ Siegel R, Ma J, Zou Z, et al. Cancer statistics,2014［J］. CA Cancer J Clin， 2014, 64(1):929. ［21］ Singh S, Trevino J, BoraSinghal N, et al. EGFR/Src/Akt signaling modulates Sox2 expression and selfrenewal of stemlike sidepopulation cells in nonsmall cell lung cancer［J］. Mol Cancer， 2012, 11:73. ［22］ Hua S, Xiaotao X, Renhua G, et al. Reduced miR31 and let7 maintain the balance between differentiation and quiescence in lung cancer stemlike side population cells［J］.Biomed Pharmacother， 2012,66(2):8997. ［23］ Hayashi S, Fujita K, Matsumoto S, et al. Isolation and identification of cancer stem cells from a side population of a human hepatoblastoma cell line, HuH6 clone5［J］. Pediatr Surg Int， 2011, 27(1):916. ［24］ Zhai JM, Yin XY, Hou X, et al. Analysis of the genomewide DNA methylation profile of side population cells in hepatocellular carcinoma［J］. Dig Dis Sci， 2013, 58(7):19341947. ［25］ Meyer HJ, Wilke H. Gastric cancer:current status of multimodalitytreatment［J］. Zentralbl Chir， 2011, 136(4):317324. ［26］ Dikken JL, van de Velde CJ, Coit DG, et al. Treatment of resectable gastric cancer［J］. Therap Adv Gastroenterol， 2012, 5(1):4969. ［27］ Zhang HH, Cai AZ, Wei XM, et al. Characterization of cancer stemlike cells in the side population cells of human gastric cancer cell line MKN45［J］. J Zhejiang Univ Sci B， 2013, 14(3):216223. ［28］ Li R, Wu X, Wei H, et al. Characterization of side population cells isolated from the gastric cancer cell line SGC7901［J］.Oncol Lett， 2013, 5(3):877883. ［29］ Hasegawa T, Yashiro M, Nishii T, et al. Cancerassociated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factorβ signaling［J］. Int J Cancer， 2014, 134(8):17851795. ［30］ López J, Poitevin A, MendozaMartínez V, et al. Cancerinitiating cells derived from eslablished cervical cell lines exhibit stemcell markers and increased radioresistance［J］. BMC Cancer， 2012, 12:48. ［31］ Shishido Y, Ueno S, Yamazaki R, et al. ABCG2 inhibitor YHO13351 sensitizes cancer stem/initiatinglike side population cells to irinotecan［J］. Anticancer Res， 2013, 33(4):13791386. ［32］ Qi W, Zhao C, Zhao L, et al. Sorting and identification of side population cells in the human cervical cancer cell line HeLa［J］. Cancer Cell Int， 2014, 14(1):3.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.